BlackRock, Inc. 13D and 13G filings for AbbVie Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | AbbVie Inc. ABBV |
BLACKROCK INC BLK |
143,180,060 8.100% |
4,477,302 (+3.23%) |
Filing |
| 2023-02-15 5:45 pm Purchase |
2022-12-31 | 13G | AbbVie Inc. ABBV |
BLACKROCK INC BLK |
138,702,758 7.800% |
10,505,203 (+8.19%) |
Filing |
| 2022-02-03 4:29 pm Purchase |
2021-12-31 | 13G | AbbVie Inc. ABBV |
BLACKROCK INC BLK |
128,197,555 7.300% |
3,774,071 (+3.03%) |
Filing |
| 2021-01-28 6:11 pm Purchase |
2020-12-31 | 13G | AbbVie Inc. ABBV |
BLACKROCK INC BLK |
124,423,484 7.000% |
25,829,674 (+26.20%) |
Filing |